RNF31 and Patent ductus arteriosus: Together, our findings from in vivo experiments demonstrate that loss of Rnf31 and Vps4b sensitize PDA to CTL-mediated killing not only in a cell-autonomous manner, but also in a non-cell-autonomous manner through increasing CTL effector function.